第1页共30页编号：时间：2021年x月x日书山有路勤为径，学海无涯苦作舟页码：第1页共30页《兼并重组与公司控制》课程案例分析案例题目：拜耳医药收购东盛科技“白加黑”案例分析专业：会计学学号：_______________________姓名：___________________论文总成绩：分第2页共30页第1页共30页编号：时间：2021年x月x日书山有路勤为径，学海无涯苦作舟页码：第2页共30页其中：背景分析：（分）分析问题：（分）观点结论：（分）论文规范：（分）二○一三年五月并购案例分析报告报告目录1.案例简介..............................................................................................11.1大事记描述··························································11.2案例选取理由·······················································12.并购行业背景........................................................................................12.1中国医药市场的行业状况···········································12.2中国医药市场的外资进入···········································32.3中国医药行业市场的并购发展和特点·····························43.并购企业介绍........................................................................................73.1拜耳公司·····························································73.1.1基本情况·························································73.1.2历史沿革·························································83.1.3财务状况·························································83.2东盛科技公司························································9第3页共30页第2页共30页编号：时间：2021年x月x日书山有路勤为径，学海无涯苦作舟页码：第3页共30页3.1.1基本情况·························································93.2.2历史沿革·························································93.2.3财务状况·················································114.并购动因..............................................................................................114.1中国国内医药收购大环境··········································114.2企业并购需要·······················································124.2.1拜耳并购需要····················································124.2.2东盛科技被并购需要·············································135.并购过程..............................................................................................135.1并购过程大事记····················································135.2事记细化描述·································...
VIP
